2561513-58-2 Usage
General Description
The chemical "(R)-N-((S)-(2-(di-tert-butylphosphanyl)phenyl)(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)methyl)-N,2-dimethylpropane-2-sulfinamide" is a complex organic compound consisting of a sulfinamide group and various substituted aromatic and aliphatic moieties. The molecule contains a chiral center and displays stereochemistry. Its long and complex chemical name indicates its highly specific and unique structure, which may have potential applications in the field of organic synthesis, pharmaceuticals, or materials science. Therefore, further research and investigation are likely needed to fully understand the properties and potential uses of this chemical compound.
Check Digit Verification of cas no
The CAS Registry Mumber 2561513-58-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 2,5,6,1,5,1 and 3 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 2561513-58:
(9*2)+(8*5)+(7*6)+(6*1)+(5*5)+(4*1)+(3*3)+(2*5)+(1*8)=162
162 % 10 = 2
So 2561513-58-2 is a valid CAS Registry Number.
2561513-58-2Relevant articles and documents
Design and Synthesis of TY-Phos and Application in Palladium-Catalyzed Enantioselective Fluoroarylation of gem-Difluoroalkenes
Li, Zhiming,Lin, Tao-Yan,Liu, Yu,Pan, Zhangjin,Tu, Youshao,Wu, Hai-Hong,Zhang, Junliang,Zhu, Shuai
supporting information, p. 22957 - 22962 (2020/10/19)
The first example of highly enantioselective fluoroarylation of gem-difluoroalkenes with aryl halides is presented by using a new chiral sulfinamide phosphine (Sadphos) type ligand TY-Phos. N-Me-TY-Phos can be easily synthesized on a gram scale from readily available starting materials in three steps. Salient features of this work including readily available starting materials, good yields, high enantioselectivities as well as broad substrate scope make this approach very practical and attractive. Notably, the asymmetric synthesis of an analogue of a biologically active molecule is also reported.